BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1173117)

  • 1. Hyperlipoproteinemia in occlusive cerebrovascular disease.
    Mathew NT; Davis D; Meyer JS; Chandar K
    JAMA; 1975 Apr; 232(3):262-6. PubMed ID: 1173117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperlipoproteinemia and cerebral strokes.
    Dekaban AS; Steusing JK; Stevens H
    Can J Neurol Sci; 1977 Feb; 4(1):13-7. PubMed ID: 837259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stroke - the role of hyperlipoproteinemia. I. Lipid metabolism and various arteriosclerosis risk factors in a control group].
    Hulanicka K; Piechocki DW; Guzowski K
    Neurol Neurochir Pol; 1981; 15(4):453-57. PubMed ID: 7329510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of plasma lipids and lipoprotein concentration to cerebral atherosclerosis and electrocardiographic findings.
    Ballantyne D; Grossart KW; Ballantyne JP; Young A; Lawrie TD
    J Neurol Sci; 1974 Oct; 23(2):323-9. PubMed ID: 4427120
    [No Abstract]   [Full Text] [Related]  

  • 5. [Frequency of abnormal lipid values and of hyperlipoproteinaemia in in-patients of a general hospital (author's transl)].
    Schräpler P; Petrides P; Schmidt FH; el-Hamalawi J; Stork H
    Dtsch Med Wochenschr; 1974 Aug; 99(34):1682-6. PubMed ID: 4368141
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudo-Sjögren syndrome with hyperlipoproteinemia.
    Goldman JA; Julian EH
    JAMA; 1977 Apr; 237(15):1582-4. PubMed ID: 576655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early manifestations and investigation of cerebral arteriosclerosis.
    Gilroy J
    Practitioner; 1976 Jul; 217(1297):66-73. PubMed ID: 792862
    [No Abstract]   [Full Text] [Related]  

  • 8. [Statistics for the study of cerebrovascular insufficiency due to occlusive or stenotic lesions of the carotid artery. I].
    Tedeschi G; Signorelli CD; De Divitiis E
    Rass Int Clin Ter; 1971 May; 51(9):534-42. PubMed ID: 5088698
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipid composition of circulating lipoproteins in various types of hyperlipoproteinemia (author's transl)].
    Jaillard J; Sezille G; Dewailly P; Fruchart JC
    Diabete Metab; 1977 Sep; 3(3):159-64. PubMed ID: 199484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Distribution and risk factors of steno-occlusive lesions in patients with ischemic cerebrovascular disease].
    Li D; Wang ML; Li SM; Ling F
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1158-62. PubMed ID: 18844107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipoprotein(a): structure, metabolism and atherosclerotic disease].
    Postorino G; Altavilla R
    Minerva Med; 1992 Oct; 83(10):581-8. PubMed ID: 1461528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial type IV hyperlipoproteinemia.
    Schreibman PH; Wilson DE; Arky RA
    N Engl J Med; 1969 Oct; 281(18):981-5. PubMed ID: 5824739
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebrovascular arteriopathy (arteriosclerosis) and ischemic childhood stroke.
    Daniels SR; Bates S; Lukin RR; Benton C; Third J; Glueck CJ
    Stroke; 1982; 13(3):360-5. PubMed ID: 7080131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study on the relationship between diabetes, hyperlipoproteinemia and atheromatosis].
    Righetti A; Scherrer JR; Micheli H; Pometta D
    Schweiz Med Wochenschr; 1973 May; 103(18):668-73. PubMed ID: 4702987
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cerebral consequences of essential arterial hypertension, in relation to the stage and clinical form of the disease (hemodynamic study)].
    Hărăguş S; Mureşan IG; Vlaicu R; Butnaru M
    Med Interna (Bucur); 1970 Sep; 22(9):1033-44. PubMed ID: 5491372
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
    Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Takeda R
    Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in serum lipoproteins in cerebrovascular disease (author's transl)].
    Bruck J; Fischer M; Tschabitscher H
    Wien Klin Wochenschr; 1981 Oct; 93(19):604-9. PubMed ID: 7324470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frequency and distribution of types of hyperlipoproteinemia with life-shortening risk factors among ambulant patients (author's transl)].
    Mertz DP; Hohneck A
    Med Klin; 1975 Jul; 70(28-29):1209-13. PubMed ID: 170497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stroke - the role of hyperlipoproteinemia. II. Lipid metabolism in stroke patients].
    Hulanicka K; Piechocki DW; Guzowski K
    Neurol Neurochir Pol; 1981; 15(4):459-67. PubMed ID: 7329511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Address of the president-elect: the indication for various methods of treatment of occlusive cerebrovascular disease.
    Millikan CH
    Trans Am Neurol Assoc; 1973; 98():206-18. PubMed ID: 4784937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.